Body Composition Changes Research published in Diabetes, Obesity & Metabolism in 2024 specifically addressed body composition during GLP-1 treatment, noting that supportive nutrition including adequate minerals may help optimize outcomes (PMID: 39344838)
GLP-1 medication changes may support long-term weight management Patients who switch obesity drugs after less than a year stay better engaged with their treatment, UTSW researchers find DALLAS March 10, 2026 Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didnt switch, according to a new study by UT Southwestern Medical Center researchers
Regulatory evolution The FDA has increasingly focused on the peptide grey market, particularly for GLP-1 agonists
Additionally, significant improvements were reported in cognitive function test performance, suggesting possible neurovascular benefits of beetroot consumption in T2DM
Once you've selected and paid for the first month of your chosen medication, you will need to complete an intake form for the doctor to review and approve your prescription